natgillin/translations-raw huggingface dataset:
Reproduction is authorised provided the source is acknowledged. consecutive doses should be 5 micrograms.
Reproduction is authorised provided the source is acknowledged. további dózisoknak 5 mikrogrammosnak kell lenniük.
Reproduction is authorised provided the source is acknowledged. consult their doctor.
Reproduction is authorised provided the source is acknowledged. keresnie a kezelőorvosát.
Reproduction is authorised provided the source is acknowledged. continue at a reduced dose of 20 mg/m2.
Reproduction is authorised provided the source is acknowledged. csökkenteni kell, ha a betegnél bizonyos mellékhatások jelentkeznek, illetve a kezelést le kell állítani, ha a mellékhatások 20 mg/m2 csökkentett adag mellett is fennállnak.
Reproduction is authorised provided the source is acknowledged. continue for several months to prevent the disease coming back, or for longer in patients who have had repeated periods of depression in the past.
A Duloxetine Lillyre reagáló betegek esetében a betegség visszatérésének megelőzése érdekében a kezelést több hónapig folytatni kell, vagy még annál is tovább azoknál a betegeknél, akiknél korábban ismételten depressziós időszakok léptek fel.
Reproduction is authorised provided the source is acknowledged. continuing treatment with Memantine LEK should be reassessed on a regular basis.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. controlling the growth of the lining of the womb.
Reproduction is authorised provided the source is acknowledged. receptorának működését.
Reproduction is authorised provided the source is acknowledged. damage.
Reproduction is authorised provided the source is acknowledged. eredményezhet.
Reproduction is authorised provided the source is acknowledged. day is not recommended.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. death of the parasitic organism.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. defences) how to defend itself against a disease.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. divided into two or three doses.
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. dose can be increased to 80 mg, or another medicine for hypertension can be added, such as hydrochlorothiazide.
Reproduction is authorised provided the source is acknowledged. elérni, az adag 80 mg-ra emelhető, vagy más, a hipertónia kezelésére szolgáló gyógyszerekkel, például hidroklorotiaziddal egészíthető ki.
Reproduction is authorised provided the source is acknowledged. dose for the immediate-release tablets is 1.1 mg three times per day and in case of the prolonged release tablets is 3.15 mg once a day.
Reproduction is authorised provided the source is acknowledged. hatóanyag-leadású tabletta maximális napi adagja 1,1 mg naponta háromszor, a retard tablettáé pedig 3,15 mg naponta egyszer.
Reproduction is authorised provided the source is acknowledged. dose of the sulphonylurea or insulin may be considered because of the risk of hypoglycaemia (low blood sugar).
Reproduction is authorised provided the source is acknowledged.
Reproduction is authorised provided the source is acknowledged. dose once a day for at least four weeks (in ST segment elevation myocardial infarction) or for up to 12 months (in non-ST segment elevation syndrome).
A kezelést ezután legalább négy hétig (ST-elevációs miokardiális infarktus esetén), vagy 12 hónapig bezárólag (nem ST-elevációs szindróma esetén) alkalmazott, napi egyszeri 75 mg-os dózissal folytatják.
Reproduction is authorised provided the source is acknowledged. dose should be assessed within 3 months after starting treatment, and from then on the benefits of continuing treatment with Memantine Mylan should be reassessed on a regular basis.
A kezelés megkezdésétől számított 3 hónapon belül ellenőrizni kell az adagot és azt, hogy a beteg jól tolerálja-e a gyógyszert, valamint ettől az időponttól kezdve rendszeres időközönként értékelni kell a Memantine Mylan-kezelés folytatásának előnyeit.